ARCHIVES

FDA Begins To Examine Its Role In Allowing Misleading Consumer Advertising.

This article is from The Cancer Letter archive.

Vol. 33 No. 19 | May 18, 2007

Download PDF Visit The Full Archive

Related Articles

Also C-Change new name for National Dialogue on Cancer.

January 16, 2004

In Brief: Alfred Ketcham Is New SSO President; Meyskens Receives NCI Year 2000 Award; Colman Honored

August 10, 1990

Benefits of Mammography Outweigh Harms In Women with Increased Risk, Starting at Age 40

April 27, 2012

NCI News: TCGA Project Selects First Three Cancers, Tissue Banks.

October 13, 2006

Orlando Health President Mark Rohl We Opted For A Florida-Centric Strategy

January 10, 2014

Politics May Play Role In FDA’s Avastin Decision

May 27, 2011